3 things we know (and 3 we don’t) about Pfizer’s initial COVID-19 vaccine results
San Diego scientists and trial participants are cautiously optimistic after early reports that Pfizer’s COVID-19 vaccine is highly effective
T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity
LA JOLLA, CA—Ever since SARS-CoV-2 first appeared, researchers have been trying to understand whether sometimes the immune system does more
A Vaccine against Ebola Virus
LJI Professor Erica Ollmann Saphire awarded $6.4 million for international efforts to beat COVID-19
LA JOLLA—The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, has awarded more
La Jolla Institute for Immunology Receives $1 Million from GHR Foundation in Support of COVID-19 Research
LA JOLLA, CA – La Jolla Institute for Immunology (LJI) has announced a $1 million gift from GHR Foundation, an
From Wuhan to San Diego—How a mutation on the novel coronavirus has come to dominate the globe
Flashback to mid-March: the novel coronavirus had reached San Diego, California. Few people could get tested, and even less was
What we can learn from SARS
LA JOLLA, CA—Seventeen years ago, another viral outbreak was in the news. People wore masks, many were nervous to fly.
